marketcaparena
Search

    DGX

    QUEST DIAGNOSTICS INC

    Company overview

    Market capitalization
    $26.23B
    Employees
    57,000
    Latest publication
    2026-09-29
    About QUEST DIAGNOSTICS INC

    Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20182018-03-31 · USDQ1 20162016-03-31 · USDQ4 20082008-12-31 · USDQ2 20082008-06-30 · USDQ1 20082008-03-31 · USDQ2 20072007-06-30 · USDQ2 20062006-06-30 · USD
    Total Revenue3,043,000,000USD1,884,000,000USD1,863,000,000USD1,800,306,000USD1,837,901,000USD1,784,637,000USD1,641,156,000USD1,584,335,000USD
    Cost Of Revenue2,016,000,000USD1,226,000,000USD1,144,000,000USD1,040,925,000USD1,083,481,000USD1,058,627,000USD968,742,000USD936,432,000USD
    Gross Profit1,027,000,000USD658,000,000USD719,000,000USD759,381,000USD754,420,000USD726,010,000USD672,414,000USD647,903,000USD
    Selling General Administrative529,000,000USD363,000,000USD442,000,000USD435,640,000USD438,037,000USD436,485,000USD395,105,000USD383,021,000USD
    Total Operating Expenses568,000,000USD386,000,000USD462,000,000USD442,324,000USD446,297,000USD445,749,000USD400,005,000USD385,278,000USD
    Operating Income459,000,000USD272,000,000USD257,000,000USD317,057,000USD308,123,000USD280,261,000USD272,409,000USD262,625,000USD
    Total Other Income Expense Net-47,000,000USD-43,000,000USD-85,000,000USD-53,980,000USD-37,292,000USD-47,709,000USD-38,577,000USD-34,566,000USD
    Interest Income5,000,000USD———————
    Interest Expense68,000,000USD41,000,000USD36,000,000USD44,577,000USD46,876,000USD47,617,000USD39,158,000USD22,662,000USD
    Net Interest Income-63,000,000USD———————
    Income Before Tax412,000,000USD229,000,000USD172,000,000USD263,077,000USD263,005,000USD232,552,000USD233,832,000USD228,059,000USD
    Income Tax Expense88,000,000USD52,000,000USD68,000,000USD93,481,000USD100,787,000USD91,858,000USD91,853,000USD96,082,000USD
    Equity Method Income Loss10,000,000USD———————
    Net Income334,000,000USD176,000,000USD103,000,000USD169,813,000USD161,328,000USD139,607,000USD141,332,000USD131,977,000USD
    Minority Interest14,000,000USD12,000,000USD12,000,000USD8,221,000USD7,826,000USD7,054,000USD6,353,000USD5,850,000USD
    Net Income Applicable To Common Shares319,000,000USD177,000,000USD102,000,000USD169,596,000USD162,218,000USD140,694,000USD141,979,000USD155,961,000USD
    Research Development—0USD0USD0USD0USD0USD0USD0USD
    Unclassified Operating Expenses—23,000,000USD20,000,000USD6,684,000USD8,260,000USD9,264,000USD4,900,000USD—
    Net Income From Continuing Ops—177,000,000USD104,000,000USD0USD0USD0USD0USD0USD
    Ebit—270,000,000USD208,000,000USD299,109,000USD317,707,000USD215,002,000USD217,511,000USD297,326,000USD
    Ebitda—344,000,000USD270,000,000USD364,874,000USD385,132,000USD280,261,000USD272,409,000USD346,886,000USD
    Depreciation And Amortization—74,000,000USD62,000,000USD65,765,000USD67,425,000USD65,259,000USD54,898,000USD49,560,000USD
    Reconciled Depreciation—74,000,000USD62,000,000USD65,765,000USD67,425,000USD65,259,000USD54,898,000USD49,560,000USD
    Non Operating Income Net Other—10,000,000USD-39,000,000USD—————
    Discontinued Operations—0USD0USD0USD0USD0USD0USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20052005-12-31 · USDFY 20042004-12-31 · USDFY 20032003-12-31 · USDFY 20022002-12-31 · USDFY 19981998-12-31 · USDFY 19971997-12-31 · USD
    Total Revenue5,503,711,000USD5,126,601,000USD4,737,958,000USD4,108,051,000USD1,458,600,000USD1,528,700,000USD
    Cost Of Revenue3,257,335,000USD2,990,712,000USD2,768,623,000USD2,432,388,000USD813,900,000USD875,500,000USD
    Gross Profit2,246,376,000USD2,135,889,000USD1,969,335,000USD1,675,663,000USD644,700,000USD653,200,000USD
    Selling General Administrative1,257,775,000USD1,227,746,000USD1,165,700,000USD1,074,841,000USD481,600,000USD502,100,000USD
    Unclassified Operating Expenses20,490,000USD———68,800,000USD76,400,000USD
    Total Operating Expenses1,278,265,000USD1,234,449,000USD1,173,901,000USD1,083,214,000USD550,400,000USD578,500,000USD
    Operating Income968,111,000USD901,440,000USD795,434,000USD592,449,000USD94,300,000USD74,700,000USD
    Interest Expense0USD0USD0USD0USD0USD0USD
    Income Before Tax910,454,000USD835,126,000USD737,798,000USD542,377,000USD53,900,000USD-19,100,000USD
    Income Tax Expense364,177,000USD335,931,000USD301,081,000USD220,223,000USD27,000,000USD3,200,000USD
    Net Income546,277,000USD499,195,000USD436,717,000USD322,154,000USD26,900,000USD-22,300,000USD
    Ebit1,007,548,000USD880,854,000USD796,454,000USD592,449,000USD94,300,000USD74,700,000USD
    Ebitda1,183,672,000USD1,049,580,000USD950,357,000USD723,840,000USD163,100,000USD151,100,000USD
    Depreciation And Amortization176,124,000USD168,726,000USD153,903,000USD131,391,000USD68,800,000USD76,400,000USD
    Total Other Income Expense Net-57,657,000USD-76,554,000USD-58,656,000USD-50,072,000USD-40,400,000USD-93,800,000USD
    Minority Interest19,495,000USD19,353,000USD17,630,000USD14,874,000USD——
    Net Income Applicable To Common Shares546,277,000USD499,195,000USD436,717,000USD322,154,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets16,939,000,000USD16,673,000,000USD16,225,000,000USD16,197,000,000USD15,969,000,000USD15,797,000,000USD16,153,000,000USD16,095,000,000USD
    Cash And Equivalents626,000,000USD—420,000,000USD432,000,000USD319,000,000USD188,000,000USD549,000,000USD764,000,000USD
    Total Current Assets2,844,000,000USD2,566,000,000USD2,378,000,000USD2,407,000,000USD2,198,000,000USD2,075,000,000USD2,392,000,000USD2,623,000,000USD
    Other Current Assets319,000,000USD361,000,000USD361,000,000USD333,000,000USD273,000,000USD294,000,000USD351,000,000USD299,000,000USD
    Other Non Current Assets277,000,000USD———————
    Total Liabilities9,040,000,000USD———————
    Total Current Liabilities1,788,000,000USD2,177,000,000USD2,278,000,000USD2,134,000,000USD2,024,000,000USD1,441,000,000USD2,169,000,000USD2,092,000,000USD
    Other Non Current Liabilities1,059,000,000USD———————
    Total Stockholder Equity7,516,000,000USD7,366,000,000USD7,170,000,000USD7,258,000,000USD7,228,000,000USD6,929,000,000USD6,778,000,000USD6,809,000,000USD
    Total Equity Including Noncontrolling Interest7,899,000,000USD———————
    Short Long Term Debt30,000,000USD503,000,000USD707,000,000USD504,000,000USD504,000,000USD1,000,000USD764,000,000USD603,000,000USD
    Long Term Debt5,632,000,000USD5,155,000,000USD5,167,000,000USD5,171,000,000USD5,169,000,000USD5,858,000,000USD5,615,000,000USD5,648,000,000USD
    Net Receivables1,666,000,000USD1,587,000,000USD1,408,000,000USD1,456,000,000USD1,419,000,000USD1,404,000,000USD1,304,000,000USD1,376,000,000USD
    Inventory233,000,000USD225,000,000USD189,000,000USD186,000,000USD187,000,000USD189,000,000USD188,000,000USD184,000,000USD
    Property Plant Equipment Net2,897,000,000USD2,880,000,000USD2,860,000,000USD2,794,000,000USD2,775,000,000USD2,754,000,000USD2,764,000,000USD2,754,000,000USD
    Goodwill9,112,000,000USD———————
    Intangible Assets1,672,000,000USD1,717,000,000USD1,636,000,000USD1,662,000,000USD1,706,000,000USD1,725,000,000USD1,763,000,000USD1,716,000,000USD
    Accounts Payable386,000,000USD1,500,000,000USD1,600,000,000USD1,457,000,000USD1,309,000,000USD1,247,000,000USD1,389,000,000USD1,269,000,000USD
    Short Term Debt180,000,000USD677,000,000USD678,000,000USD677,000,000USD675,000,000USD174,000,000USD775,000,000USD779,000,000USD
    Common Stock2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD
    Retained Earnings10,374,000,000USD10,151,000,000USD9,994,000,000USD9,837,000,000USD9,682,000,000USD9,490,000,000USD9,360,000,000USD9,222,000,000USD
    Accumulated Other Comprehensive Income-62,000,000USD-43,000,000USD-27,000,000USD-40,000,000USD-16,000,000USD-83,000,000USD-88,000,000USD-15,000,000USD
    Total Liab—9,007,000,000USD8,939,000,000USD8,821,000,000USD8,623,000,000USD8,754,000,000USD9,257,000,000USD9,174,000,000USD
    Capital Stock—2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD
    Good Will—9,120,000,000USD8,945,000,000USD8,901,000,000USD8,883,000,000USD8,849,000,000USD8,856,000,000USD8,605,000,000USD
    Cash—393,000,000USD420,000,000USD432,000,000USD319,000,000USD188,000,000USD549,000,000USD764,000,000USD
    Cash And Short Term Investments—393,000,000USD420,000,000USD432,000,000USD319,000,000USD188,000,000USD549,000,000USD764,000,000USD
    Net Debt—6,587,000,000USD6,499,000,000USD5,950,000,000USD6,065,000,000USD6,382,000,000USD6,376,000,000USD6,206,000,000USD
    Short Long Term Debt Total—6,980,000,000USD6,919,000,000USD6,382,000,000USD6,384,000,000USD6,570,000,000USD6,925,000,000USD6,970,000,000USD
    Long Term Investments—134,000,000USD136,000,000USD137,000,000USD136,000,000USD134,000,000USD123,000,000USD125,000,000USD
    Property Plant Equipment Gross—2,880,000,000USD6,833,000,000USD2,794,000,000USD2,775,000,000USD2,754,000,000USD6,422,000,000USD2,754,000,000USD
    Common Stock Shares Outstanding—112,000,000shares112,000,000shares113,000,000shares113,000,000shares113,000,000shares113,000,000shares113,000,000shares
    Non Current Assets Total—14,107,000,000USD13,847,000,000USD13,790,000,000USD13,771,000,000USD13,722,000,000USD13,761,000,000USD13,472,000,000USD
    Non Current Liabilities Total—6,830,000,000USD6,661,000,000USD6,687,000,000USD6,599,000,000USD7,313,000,000USD7,088,000,000USD7,082,000,000USD
    Non Current Liabilities Other—1,022,000,000USD957,000,000USD982,000,000USD890,000,000USD917,000,000USD938,000,000USD891,000,000USD
    Non Currrent Assets Other—256,000,000USD270,000,000USD296,000,000USD271,000,000USD260,000,000USD255,000,000USD272,000,000USD
    Net Working Capital—389,000,000USD100,000,000USD273,000,000USD174,000,000USD634,000,000USD223,000,000USD531,000,000USD
    Unclassified Current Liabilities—-503,000,000USD-707,000,000USD-504,000,000USD-504,000,000USD—-764,000,000USD-603,000,000USD
    Unclassified Non Current Liabilities—653,000,000USD537,000,000USD534,000,000USD540,000,000USD538,000,000USD535,000,000USD543,000,000USD
    Unclassified Equity—-2,746,000,000USD-2,801,000,000USD-2,543,000,000USD-2,442,000,000USD-2,482,000,000USD-2,498,000,000USD-2,402,000,000USD
    Other Assets——270,000,000USD296,000,000USD271,000,000USD260,000,000USD255,000,000USD272,000,000USD
    Unclassified Non Current Assets——-270,000,000USD-296,000,000USD-271,000,000USD-260,000,000USD-255,000,000USD-272,000,000USD
    Other Current Liab————40,000,000USD20,000,000USD5,000,000USD44,000,000USD
    Current Deferred Revenue———————-1,313,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets16,225,000,000USD16,153,000,000USD14,022,000,000USD12,837,000,000USD13,611,000,000USD14,026,000,000USD12,843,000,000USD11,003,000,000USD
    Intangible Assets1,636,000,000USD1,763,000,000USD1,166,000,000USD1,092,000,000USD1,167,000,000USD1,167,000,000USD1,121,000,000USD1,207,000,000USD
    Other Current Assets361,000,000USD351,000,000USD286,000,000USD196,000,000USD223,000,000USD157,000,000USD112,000,000USD144,000,000USD
    Total Liab8,939,000,000USD9,257,000,000USD7,604,000,000USD6,830,000,000USD7,049,000,000USD7,135,000,000USD7,080,000,000USD5,659,000,000USD
    Total Stockholder Equity7,170,000,000USD6,778,000,000USD6,307,000,000USD5,893,000,000USD6,444,000,000USD6,759,000,000USD5,641,000,000USD5,216,000,000USD
    Common Stock2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD
    Capital Stock2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD
    Retained Earnings9,994,000,000USD9,360,000,000USD8,825,000,000USD8,290,000,000USD7,649,000,000USD9,303,000,000USD8,174,000,000USD7,602,000,000USD
    Good Will8,945,000,000USD8,856,000,000USD7,733,000,000USD7,220,000,000USD7,095,000,000USD6,873,000,000USD6,619,000,000USD6,563,000,000USD
    Other Assets270,000,000USD255,000,000USD198,000,000USD144,000,000USD163,000,000USD1,301,000,000USD64,000,000USD56,000,000USD
    Cash420,000,000USD549,000,000USD686,000,000USD315,000,000USD872,000,000USD1,158,000,000USD1,192,000,000USD135,000,000USD
    Cash And Equivalents420,000,000USD549,000,000USD686,000,000USD315,000,000USD872,000,000USD1,158,000,000USD1,192,000,000USD135,000,000USD
    Cash And Short Term Investments420,000,000USD549,000,000USD686,000,000USD315,000,000USD872,000,000USD1,158,000,000USD1,192,000,000USD135,000,000USD
    Total Current Assets2,378,000,000USD2,392,000,000USD2,372,000,000USD1,898,000,000USD2,741,000,000USD3,058,000,000USD2,490,000,000USD1,390,000,000USD
    Total Current Liabilities2,278,000,000USD2,169,000,000USD1,815,000,000USD1,551,000,000USD1,753,000,000USD1,776,000,000USD1,990,000,000USD1,485,000,000USD
    Net Debt6,499,000,000USD6,538,000,000USD4,812,000,000USD4,399,000,000USD3,901,000,000USD3,650,000,000USD4,224,000,000USD3,856,000,000USD
    Short Term Debt678,000,000USD937,000,000USD585,000,000USD247,000,000USD269,000,000USD296,000,000USD1,037,000,000USD562,000,000USD
    Short Long Term Debt707,000,000USD764,000,000USD432,000,000USD2,000,000USD2,000,000USD2,000,000USD892,000,000USD562,000,000USD
    Short Long Term Debt Total6,919,000,000USD7,087,000,000USD5,498,000,000USD4,714,000,000USD4,773,000,000USD4,808,000,000USD5,416,000,000USD3,991,000,000USD
    Long Term Debt5,167,000,000USD5,615,000,000USD4,410,000,000USD3,978,000,000USD4,010,000,000USD4,013,000,000USD3,966,000,000USD3,429,000,000USD
    Long Term Investments136,000,000USD123,000,000USD135,000,000USD132,000,000USD141,000,000USD521,000,000USD482,000,000USD436,000,000USD
    Net Receivables1,408,000,000USD1,304,000,000USD1,210,000,000USD1,195,000,000USD1,438,000,000USD1,520,000,000USD1,063,000,000USD1,012,000,000USD
    Inventory189,000,000USD188,000,000USD190,000,000USD192,000,000USD208,000,000USD223,000,000USD123,000,000USD99,000,000USD
    Accounts Payable1,600,000,000USD287,000,000USD378,000,000USD324,000,000USD357,000,000USD446,000,000USD263,000,000USD222,000,000USD
    Property Plant Equipment Net2,860,000,000USD2,764,000,000USD2,418,000,000USD2,351,000,000USD2,304,000,000USD2,231,000,000USD1,971,000,000USD1,288,000,000USD
    Property Plant Equipment Gross6,833,000,000USD6,422,000,000USD5,834,000,000USD2,351,000,000USD2,304,000,000USD2,231,000,000USD1,971,000,000USD1,288,000,000USD
    Accumulated Other Comprehensive Income-27,000,000USD-88,000,000USD-14,000,000USD-21,000,000USD-14,000,000USD-21,000,000USD-39,000,000USD-59,000,000USD
    Common Stock Shares Outstanding113,000,000shares113,000,000shares113,000,000shares118,000,000shares128,000,000shares136,000,000shares136,000,000shares139,000,000shares
    Non Current Assets Total13,847,000,000USD13,761,000,000USD11,650,000,000USD10,939,000,000USD10,870,000,000USD10,968,000,000USD10,353,000,000USD9,613,000,000USD
    Non Current Liabilities Total6,661,000,000USD7,088,000,000USD5,789,000,000USD5,279,000,000USD5,296,000,000USD5,359,000,000USD5,090,000,000USD4,174,000,000USD
    Non Current Liabilities Other957,000,000USD938,000,000USD876,000,000USD812,000,000USD792,000,000USD847,000,000USD711,000,000USD745,000,000USD
    Non Currrent Assets Other270,000,000USD255,000,000USD198,000,000USD144,000,000USD163,000,000USD176,000,000USD160,000,000USD119,000,000USD
    Net Working Capital100,000,000USD223,000,000USD557,000,000USD347,000,000USD988,000,000USD1,282,000,000USD500,000,000USD-95,000,000USD
    Unclassified Non Current Assets-270,000,000USD-255,000,000USD-198,000,000USD-144,000,000USD-163,000,000USD-1,301,000,000USD——
    Unclassified Current Liabilities-707,000,000USD-764,000,000USD-948,000,000USD——41,000,000USD-865,000,000USD-562,000,000USD
    Unclassified Non Current Liabilities537,000,000USD535,000,000USD503,000,000USD-323,000,000USD-298,000,000USD-348,000,000USD-270,000,000USD-652,000,000USD
    Unclassified Equity-2,801,000,000USD-2,498,000,000USD-2,508,000,000USD2,293,000,000USD2,258,000,000USD2,839,000,000USD2,720,000,000USD2,665,000,000USD
    Other Current Liab—945,000,000USD852,000,000USD978,000,000USD1,117,000,000USD991,000,000USD663,000,000USD684,000,000USD
    Current Deferred Revenue——516,000,000USD————17,000,000USD
    Other Liab———812,000,000USD792,000,000USD847,000,000USD683,000,000USD652,000,000USD
    Treasury Stock———-4,673,000,000USD-3,453,000,000USD-5,366,000,000USD-5,218,000,000USD-4,996,000,000USD
    Net Tangible Assets———-1,853,000,000USD-1,818,000,000USD-700,000,000USD-1,610,000,000USD-2,477,000,000USD
    Short Term Investments————44,000,000USD521,000,000USD——
    Unclassified Current Assets————-44,000,000USD-521,000,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation293,000,000USD
    Stock Based Compensation43,000,000USD
    Deferred Income Tax46,000,000USD
    Other Non Cash Items-14,000,000USD
    Change To Account Receivables-259,000,000USD
    Change To Liabilities130,000,000USD
    Change In Working Capital-125,000,000USD
    Operating Cash Flow875,000,000USD
    Capital Expenditures-252,000,000USD
    Other Investing Activities-42,000,000USD
    Unclassified Investing Cash Flow8,000,000USD
    Investing Cash Flow-286,000,000USD
    Net Debt Issuance-7,000,000USD
    Net Common Stock Issuance-140,000,000USD
    Common Dividends Paid-184,000,000USD
    Other Financing Activities-109,000,000USD
    Unclassified Financing Cash Flow59,000,000USD
    Financing Cash Flow-381,000,000USD
    Effect Of Forex Changes On Cash-2,000,000USD
    Change In Cash206,000,000USD
    End Cash Flow626,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income264,000,000USD245,000,000USD259,000,000USD296,000,000USD235,000,000USD222,000,000USD237,000,000USD228,000,000USD
    Depreciation147,000,000USD145,000,000USD142,000,000USD143,000,000USD140,000,000USD135,000,000USD125,000,000USD117,000,000USD
    Stock Based Compensation20,000,000USD25,000,000USD20,000,000USD21,000,000USD22,000,000USD27,000,000USD19,000,000USD20,000,000USD
    Other Non Cash Items9,000,000USD24,000,000USD-3,000,000USD28,000,000USD-90,000,000USD67,000,000USD2,000,000USD19,000,000USD
    Change To Account Receivables-180,000,000USD47,000,000USD-38,000,000USD-14,000,000USD-101,000,000USD69,000,000USD-27,000,000USD1,000,000USD
    Change In Working Capital-210,000,000USD64,000,000USD35,000,000USD55,000,000USD-90,000,000USD13,000,000USD-42,000,000USD-6,000,000USD
    Total Cash From Operating Activities278,000,000USD465,000,000USD563,000,000USD544,000,000USD314,000,000USD464,000,000USD356,000,000USD360,000,000USD
    Capital Expenditures-114,000,000USD-158,000,000USD-144,000,000USD-108,000,000USD-117,000,000USD-123,000,000USD-106,000,000USD-92,000,000USD
    Free Cash Flow164,000,000USD307,000,000USD419,000,000USD436,000,000USD197,000,000USD341,000,000USD250,000,000USD268,000,000USD
    Total Cashflows From Investing Activities-152,000,000USD-191,000,000USD-201,000,000USD-124,000,000USD-115,000,000USD-502,000,000USD-1,633,000,000USD-200,000,000USD
    Net Borrowings-1,000,000USD-1,000,000USD0USD-216,000,000USD-385,000,000USD-1,000,000USD1,845,000,000USD—
    Total Cash From Financing Activities-152,000,000USD-287,000,000USD-247,000,000USD-293,000,000USD-561,000,000USD-170,000,000USD1,770,000,000USD-363,000,000USD
    Dividends Paid-88,000,000USD-90,000,000USD-89,000,000USD-90,000,000USD-84,000,000USD-84,000,000USD-84,000,000USD-84,000,000USD
    Change In Cash-27,000,000USD-12,000,000USD113,000,000USD131,000,000USD-361,000,000USD-215,000,000USD493,000,000USD-203,000,000USD
    Begin Period Cash Flow420,000,000USD432,000,000USD319,000,000USD188,000,000USD549,000,000USD764,000,000USD271,000,000USD474,000,000USD
    End Period Cash Flow393,000,000USD420,000,000USD432,000,000USD319,000,000USD188,000,000USD549,000,000USD764,000,000USD271,000,000USD
    Other Cashflows From Financing Activities-128,000,000USD86,000,000USD-177,000,000USD-203,000,000USD-121,000,000USD66,000,000USD-15,000,000USD6,000,000USD
    Unclassified Operating Cash Flow48,000,000USD-38,000,000USD110,000,000USD—97,000,000USD—15,000,000USD-18,000,000USD
    Unclassified Investing Cash Flow-38,000,000USD-50,000,000USD167,000,000USD107,000,000USD115,000,000USD119,000,000USD100,000,000USD94,000,000USD
    Unclassified Financing Cash Flow65,000,000USD18,000,000USD169,000,000USD174,000,000USD——25,000,000USD-285,000,000USD
    Sale Purchase Of Stock—-300,000,000USD-150,000,000USD42,000,000USD29,000,000USD-151,000,000USD-1,000,000USD—
    Other Cashflows From Investing Activities—17,000,000USD-23,000,000USD1,000,000USD2,000,000USD4,000,000USD6,000,000USD-2,000,000USD
    Investments——-201,000,000USD-124,000,000USD-115,000,000USD-502,000,000USD-1,633,000,000USD-200,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income1,046,000,000USD921,000,000USD908,000,000USD1,015,000,000USD2,080,000,000USD1,499,000,000USD906,000,000USD788,000,000USD
    Depreciation570,000,000USD493,000,000USD439,000,000USD437,000,000USD408,000,000USD361,000,000USD329,000,000USD309,000,000USD
    Stock Based Compensation88,000,000USD88,000,000USD77,000,000USD77,000,000USD79,000,000USD97,000,000USD56,000,000USD61,000,000USD
    Other Non Cash Items27,000,000USD20,000,000USD42,000,000USD69,000,000USD-364,000,000USD-59,000,000USD-98,000,000USD18,000,000USD
    Change To Account Receivables-106,000,000USD-71,000,000USD-15,000,000USD246,000,000USD81,000,000USD-455,000,000USD-63,000,000USD-65,000,000USD
    Change In Working Capital50,000,000USD-201,000,000USD-145,000,000USD119,000,000USD87,000,000USD22,000,000USD35,000,000USD-49,000,000USD
    Total Cash From Operating Activities1,886,000,000USD1,334,000,000USD1,272,000,000USD1,718,000,000USD2,233,000,000USD2,005,000,000USD1,243,000,000USD1,200,000,000USD
    Capital Expenditures-527,000,000USD-425,000,000USD-408,000,000USD-404,000,000USD-403,000,000USD-418,000,000USD-400,000,000USD-383,000,000USD
    Free Cash Flow1,359,000,000USD909,000,000USD864,000,000USD1,314,000,000USD1,830,000,000USD1,587,000,000USD843,000,000USD817,000,000USD
    Total Cashflows From Investing Activities-631,000,000USD-2,548,000,000USD-1,061,000,000USD-543,000,000USD21,000,000USD-772,000,000USD-411,000,000USD-801,000,000USD
    Net Borrowings-602,000,000USD1,543,000,000USD748,000,000USD-2,000,000USD-2,000,000USD-805,000,000USD832,000,000USD124,000,000USD
    Total Cash From Financing Activities-1,388,000,000USD1,084,000,000USD160,000,000USD-1,732,000,000USD-2,540,000,000USD-1,267,000,000USD225,000,000USD-401,000,000USD
    Dividends Paid-353,000,000USD-331,000,000USD-314,000,000USD-305,000,000USD-309,000,000USD-297,000,000USD-286,000,000USD-266,000,000USD
    Sale Purchase Of Stock-450,000,000USD-151,000,000USD-275,000,000USD-1,408,000,000USD-2,199,000,000USD-325,000,000USD-353,000,000USD-322,000,000USD
    Change In Cash-129,000,000USD-137,000,000USD371,000,000USD-557,000,000USD-286,000,000USD-34,000,000USD1,057,000,000USD-2,000,000USD
    Begin Period Cash Flow549,000,000USD686,000,000USD315,000,000USD872,000,000USD1,158,000,000USD1,192,000,000USD135,000,000USD137,000,000USD
    End Period Cash Flow420,000,000USD549,000,000USD686,000,000USD315,000,000USD872,000,000USD1,158,000,000USD1,192,000,000USD135,000,000USD
    Other Cashflows From Investing Activities-3,000,000USD41,000,000USD-42,000,000USD-139,000,000USD424,000,000USD-354,000,000USD-11,000,000USD-383,000,000USD
    Other Cashflows From Financing Activities-62,000,000USD23,000,000USD1,000,000USD-17,000,000USD-159,000,000USD-29,000,000USD-87,000,000USD63,000,000USD
    Unclassified Operating Cash Flow105,000,000USD—-49,000,000USD—-57,000,000USD85,000,000USD15,000,000USD73,000,000USD
    Unclassified Investing Cash Flow-101,000,000USD384,000,000USD510,000,000USD543,000,000USD-752,000,000USD772,000,000USD411,000,000USD766,000,000USD
    Unclassified Financing Cash Flow79,000,000USD———129,000,000USD189,000,000USD119,000,000USD—
    Investments—-2,548,000,000USD-1,121,000,000USD-543,000,000USD752,000,000USD-772,000,000USD-411,000,000USD-801,000,000USD
    Change To Liabilities———-180,000,000USD35,000,000USD474,000,000USD102,000,000USD-15,000,000USD
    Cash And Cash Equivalents Changes———-557,000,000USD-286,000,000USD-34,000,000USD1,057,000,000USD-2,000,000USD
    Change To Inventory————-20,000,000USD—29,000,000USD4,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30SegmentAll Other Segments65,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentDiagnostic Information Services Business2,978,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentAll Other Segments63,000,000USD0001022079-26-000043
    Q1 2026Quarterly · 2026-03-31SegmentDiagnostic Information Services Business2,832,000,000USD0001022079-26-000043
    Q4 2025Quarterly · 2025-12-31SegmentAll Other Segments64,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentDiagnostic Information Services Business2,742,000,000USDLegacy provider
    FY 2025Yearly · 2025-12-31SegmentAll Other Segments250,000,000USD0001022079-26-000015
    FY 2025Yearly · 2025-12-31SegmentDiagnostic Information Services Business10,785,000,000USD0001022079-26-000015
    Q3 2025Quarterly · 2025-09-30SegmentAll Other Segments61,000,000USD0001022079-25-000218
    Q3 2025Quarterly · 2025-09-30SegmentDiagnostic Information Services Business2,755,000,000USD0001022079-25-000218
    Q2 2025Quarterly · 2025-06-30SegmentAll Other Segments62,000,000USD0001022079-25-000175
    Q2 2025Quarterly · 2025-06-30SegmentDiagnostic Information Services Business2,699,000,000USD0001022079-25-000175
    Q1 2025Quarterly · 2025-03-31SegmentAll Other Segments63,000,000USD0001022079-26-000043
    Q1 2025Quarterly · 2025-03-31SegmentDiagnostic Information Services Business2,589,000,000USD0001022079-26-000043
    Q4 2024Quarterly · 2024-12-31SegmentAll Other Segments65,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentDiagnostic Information Services Business2,556,000,000USDLegacy provider
    FY 2024Yearly · 2024-12-31SegmentAll Other Segments258,000,000USD0001022079-26-000015
    FY 2024Yearly · 2024-12-31SegmentDiagnostic Information Services Business9,614,000,000USD0001022079-26-000015
    Q3 2024Quarterly · 2024-09-30SegmentAll Other Segments61,000,000USD0001022079-25-000218
    Q3 2024Quarterly · 2024-09-30SegmentDiagnostic Information Services Business2,427,000,000USD0001022079-25-000218
    FY 2023Yearly · 2023-12-31SegmentAll Other Segments276,000,000USD0001022079-26-000015
    FY 2023Yearly · 2023-12-31SegmentDiagnostic Information Services Business8,976,000,000USD0001022079-26-000015
    FY 2022Yearly · 2022-12-31SegmentAll Other Segments274,000,000USD0001022079-25-000044
    FY 2022Yearly · 2022-12-31SegmentDiagnostic Information Services Business9,609,000,000USD0001022079-25-000044
    Q3 2022Quarterly · 2022-09-30ProductAllotherservices67,000,000USD0001022079-22-000140
    Q3 2022Quarterly · 2022-09-30ProductAnatomicpathologytestingservices149,000,000USD0001022079-22-000140
    Q3 2022Quarterly · 2022-09-30ProductCOVID19Testing Services316,000,000USD0001022079-22-000140
    Q3 2022Quarterly · 2022-09-30ProductGenebasedandesoterictestingservices835,000,000USD0001022079-22-000140
    Q3 2022Quarterly · 2022-09-30ProductRoutine Clinical Testing And Other Services1,119,000,000USD0001022079-22-000140
    Q2 2022Quarterly · 2022-06-30ProductAllotherservices69,000,000USD0001022079-22-000123
    Q2 2022Quarterly · 2022-06-30ProductAnatomicpathologytestingservices144,000,000USD0001022079-22-000123
    Q2 2022Quarterly · 2022-06-30ProductCOVID19Testing Services355,000,000USD0001022079-22-000123
    Q2 2022Quarterly · 2022-06-30ProductGenebasedandesoterictestingservices787,000,000USD0001022079-22-000123
    Q2 2022Quarterly · 2022-06-30ProductRoutine Clinical Testing And Other Services1,098,000,000USD0001022079-22-000123
    Q1 2022Quarterly · 2022-03-31ProductAllotherservices70,000,000USD0001022079-22-000074
    Q1 2022Quarterly · 2022-03-31ProductAnatomicpathologytestingservices137,000,000USD0001022079-22-000074
    Q1 2022Quarterly · 2022-03-31ProductCOVID19Testing Services599,000,000USD0001022079-22-000074
    Q1 2022Quarterly · 2022-03-31ProductGenebasedandesoterictestingservices739,000,000USD0001022079-22-000074
    Q1 2022Quarterly · 2022-03-31ProductRoutine Clinical Testing And Other Services1,066,000,000USD0001022079-22-000074
    FY 2021Yearly · 2021-12-31SegmentAll Other Segments294,000,000USD0001022079-24-000041
    FY 2021Yearly · 2021-12-31SegmentDiagnostic Information Services Business10,494,000,000USD0001022079-24-000041
    Q4 2021Quarterly · 2021-12-31ProductAllotherservices70,000,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31ProductAnatomicpathologytestingservices145,000,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31ProductCOVID19Testing Services722,000,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31ProductGenebasedandesoterictestingservices906,000,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31ProductRoutineclinicaltestingservices901,000,000USDLegacy provider
    FY 2021Yearly · 2021-12-31ProductAllotherservices294,000,000USD0001022079-22-000027
    FY 2021Yearly · 2021-12-31ProductAnatomicpathologytestingservices553,000,000USD0001022079-22-000027
    FY 2021Yearly · 2021-12-31ProductCOVID19Testing Services2,770,000,000USD0001022079-22-000027
    FY 2021Yearly · 2021-12-31ProductGenebasedandesoterictestingservices2,878,000,000USD0001022079-22-000027
    FY 2021Yearly · 2021-12-31ProductRoutineclinicaltestingservices4,293,000,000USD0001022079-22-000027
    Q3 2021Quarterly · 2021-09-30ProductAllotherservices71,000,000USD0001022079-22-000140
    Q3 2021Quarterly · 2021-09-30ProductAnatomicpathologytestingservices138,000,000USD0001022079-22-000140
    Q3 2021Quarterly · 2021-09-30ProductCOVID19Testing Services709,000,000USD0001022079-22-000140
    Q3 2021Quarterly · 2021-09-30ProductGenebasedandesoterictestingservices646,000,000USD0001022079-22-000140
    Q3 2021Quarterly · 2021-09-30ProductRoutine Clinical Testing And Other Services1,210,000,000USD0001022079-22-000140
    Q2 2021Quarterly · 2021-06-30ProductAllotherservices76,000,000USD0001022079-22-000123
    Q2 2021Quarterly · 2021-06-30ProductAnatomicpathologytestingservices140,000,000USD0001022079-22-000123
    Q2 2021Quarterly · 2021-06-30ProductCOVID19Testing Services511,000,000USD0001022079-22-000123
    Q2 2021Quarterly · 2021-06-30ProductGenebasedandesoterictestingservices673,000,000USD0001022079-22-000123
    Q2 2021Quarterly · 2021-06-30ProductRoutine Clinical Testing And Other Services1,150,000,000USD0001022079-22-000123
    Q1 2021Quarterly · 2021-03-31ProductAllotherservices77,000,000USD0001022079-22-000074
    Q1 2021Quarterly · 2021-03-31ProductAnatomicpathologytestingservices130,000,000USD0001022079-22-000074
    Q1 2021Quarterly · 2021-03-31ProductCOVID19Testing Services828,000,000USD0001022079-22-000074
    Q1 2021Quarterly · 2021-03-31ProductGenebasedandesoterictestingservices653,000,000USD0001022079-22-000074
    Q1 2021Quarterly · 2021-03-31ProductRoutine Clinical Testing And Other Services1,032,000,000USD0001022079-22-000074
    FY 2020Yearly · 2020-12-31SegmentAll Other Segments298,000,000USD0001022079-23-000018
    FY 2020Yearly · 2020-12-31SegmentDiagnostic Information Services Business9,139,000,000USD0001022079-23-000018
    Q4 2020Quarterly · 2020-12-31ProductAllotherservices80,000,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31ProductAnatomicpathologytestingservices139,000,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31ProductCOVID19Testing Services1,152,000,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31ProductGenebasedandesoterictestingservices607,000,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31ProductRoutineclinicaltestingservices1,024,000,000USDLegacy provider
    FY 2020Yearly · 2020-12-31ProductAllotherservices298,000,000USD0001022079-22-000027
    FY 2020Yearly · 2020-12-31ProductAnatomicpathologytestingservices482,000,000USD0001022079-22-000027
    FY 2020Yearly · 2020-12-31ProductCOVID19Testing Services2,723,000,000USD0001022079-22-000027
    FY 2020Yearly · 2020-12-31ProductGenebasedandesoterictestingservices2,098,000,000USD0001022079-22-000027
    FY 2020Yearly · 2020-12-31ProductRoutineclinicaltestingservices3,836,000,000USD0001022079-22-000027
    FY 2019Yearly · 2019-12-31SegmentAll Other Segments321,000,000USD0001022079-22-000027
    FY 2019Yearly · 2019-12-31SegmentDiagnostic Information Services Business7,405,000,000USD0001022079-22-000027
    FY 2019Yearly · 2019-12-31ProductAllotherservices321,000,000USD0001022079-22-000027
    FY 2019Yearly · 2019-12-31ProductAnatomicpathologytestingservices579,000,000USD0001022079-22-000027
    FY 2019Yearly · 2019-12-31ProductCOVID19Testing Services0USD0001022079-22-000027
    FY 2019Yearly · 2019-12-31ProductGenebasedandesoterictestingservices2,620,000,000USD0001022079-22-000027
    FY 2019Yearly · 2019-12-31ProductRoutineclinicaltestingservices4,206,000,000USD0001022079-22-000027
    FY 2018Yearly · 2018-12-31SegmentAll Other Segments327,000,000USD0001022079-21-000029
    FY 2018Yearly · 2018-12-31SegmentDiagnostic Information Services Business7,204,000,000USD0001022079-21-000029
    FY 2018Yearly · 2018-12-31ProductAllotherservices327,000,000USD0001022079-21-000029
    FY 2018Yearly · 2018-12-31ProductAnatomicpathologytestingservices578,000,000USD0001022079-21-000029
    FY 2018Yearly · 2018-12-31ProductCOVID19Testing Services0USD0001022079-21-000029
    FY 2018Yearly · 2018-12-31ProductGenebasedandesoterictestingservices2,409,000,000USD0001022079-21-000029
    FY 2018Yearly · 2018-12-31ProductRoutineclinicaltestingservices4,217,000,000USD0001022079-21-000029
    FY 2017Yearly · 2017-12-31ProductAllotherservices335,000,000USD0001022079-20-000017
    FY 2017Yearly · 2017-12-31ProductAnatomicpathologytestingservices612,000,000USD0001022079-20-000017
    FY 2017Yearly · 2017-12-31ProductGenebasedandesoterictestingservices2,449,000,000USD0001022079-20-000017
    FY 2017Yearly · 2017-12-31ProductRoutineclinicaltestingservices4,006,000,000USD0001022079-20-000017
    FY 2016Yearly · 2016-12-31ProductAllotherservices377,000,000USD0001022079-19-000030
    FY 2016Yearly · 2016-12-31ProductAnatomicpathologytestingservices624,000,000USD0001022079-19-000030
    FY 2016Yearly · 2016-12-31ProductGenebasedandesoterictestingservices2,335,000,000USD0001022079-19-000030
    FY 2016Yearly · 2016-12-31ProductRoutineclinicaltestingservices3,878,000,000USD0001022079-19-000030

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.